Ash Access Technology ashaccess.com


Public lists: Pharma Startups (4732)

Ash Access Technology is developing and commercializing products that address high unmet need in the area of vascular access-related complications with a focus on infectious disease therapies and device performance.

Ash Access Technology is developing and commercializing products that address high unmet need in the area of vascular access-related complications with a focus on infectious disease therapies and device performance.

Company (Alive / Active)

Phone: 765-742-4813

Fax:

3601 Sagamore Parkway North
Suite B
Lafayette, 47904
Indiana, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Ash Access Technology $6M Jan 9, 2006
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Ash Access Technology Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors

Competitors

Company Status Description Investors

Spiration

Redmond, Washington, United States
AcquiredSpiration was founded to develop treatments for chronic obstructive pulmonary disease.Login to see details

ImaRx Therapeutics

Redmond, Washington, United States
Alive / ActiveWe are a biopharmaceutical company developing and commercializing therapies for vascular disorders. Our research and development efforts are focused on therapies for stroke and other vascular disorders, using our proprietary microbubble technology to treat vascular occlusions, or blood vessel blockages, as well as the resulting ischemia, which is tissue damage caused by a reduced supply of oxygen. In addition to the brain and the lungs, blood clots can block blood flow and cause damage to o...Show allLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Catheter lock solution comprising citrate and a paraben Feb 27, 2013 Apr 21, 2015 Patent
Catheter lock solution comprising citrate and a paraben Jun 02, 2010 Jul 24, 2012 Patent
Catheter lock solution comprising citrate and a paraben Feb 08, 2005 Jul 06, 2010 Patent